Introduction
Membrane proteins are among the most challenging proteins for structural characterization, as they are not readily purified into solution, but instead require detergents to solubilize them from their native lipid bilayer. For crystallization, the typical approach is either to attempt crystallization in detergent micelles, add lipids for crystallization in a bilayer-like environment (Faham & Bowie, 2002; Gourdon et al., 2011; Poulos, Morgan, Zimmer, & Faham, 2015) , or crystallize in lipidic cubic phase (Caffrey, 2015) .
Several methods have been proposed to stabilize membrane proteins in a more natural lipid environment, while keeping them in solution. One such method is to incorporate the target membrane protein into nanodiscs (Bayburt, Grinkova, & Sligar, 2002) , which are small sections of a lipid bilayer, encircled by MSPs (Membrane Scaffold Proteins). The dimension of the MSP based nanodisc and its ability to incorporate membrane proteins of various sizes is dictated by exploiting MSPs of differing lengths, with reconstitution success often requiring extensive optimization for a given protein target. While successes have been reported for single particle cryo-electron microscopy (SP cryo-EM) studies of nanodisc reconstituted membrane proteins, these have been limited to larger membrane protein targets (Baker, Fan, & Serysheva, 2015; Frauenfeld et al., 2011; Gao, Cao, Julius, & Cheng, 2016) .
A more recent alternative has been reported, which uses styrene maleic acid copolymers (SMAs) to generate SMALPs (SMA Lipid Particles), which allows for the isolation of membrane proteins directly from its native membrane, without the need for detergents (Jamshad et al., 2011) . Negative stain analysis of AcrB reconstituted into SMALPs has provided an initial proof of concept for the use of SMALPs in structural studies (Postis et al., 2015) .
Another new technological breakthrough, and the focus of this Chapter, exploits the self-assembly of lipid and saposin into a saposin-lipoprotein nanoparticle (Salipro).
The saposin protein family comprises four (saposin A-D) small proteins (~10 kDa) that derive from a precursor proteins involved as co-factors in the catabolism of sphingolipids. Crystal structures of saposin proteins have been reported with and without bound detergent/lipid (Ahn, Leyko, Alattia, Chen, & Privé, 2006; Popovic, Holyoake, Pomès, & Privé, 2012) . Frauenfeld et al. rationalized that these proteins could be exploited as scaffold proteins to reconstitute membrane proteins in a lipid environment and reported on its application to a number of membrane proteins.
Saposin A can be expressed and purified from Escherichia coli. Its general versatility lies in its ability to adapt the size of the nanoparticle to the membrane protein, adjusting to transmembrane regions of varying size (Frauenfeld et al., 2016) . This reduces the need to screen for a variety of scaffold protein constructs with varying protein to lipid ratios and thereby reduces the complexity of the reconstitution. The experimental setup is rather straightforward, where in a rapid process the saposin scaffold, lipids and membrane proteins self-assemble into robust lipid nanoparticles.
To date, mainly the human saposin A has been exploited to generate Salipro particles, however other saposins from the saposin protein family might provide additional versatility for specific uses, such as in combination with certain lipids or classes of membrane proteins.
Electron microscopy has seen rapid advances over the last few years, in what has been called the "resolution revolution" (Kühlbrandt, 2014) . For instance, new detectors allow for high-resolution data (~2 Å) to be collected, while the use of phase plates provide a boost to contrast, allowing smaller particles to be identified in the micrographs (Danev & Baumeister, 2016) . These advances coupled with the improvements to sample supports, microscopes, new software and computer hardware makes working with large cryo-EM datasets easier and allows for the visualization and atomic model building of membrane proteins.
Here we demonstrate that Salipro reconstitution can be used for structural characterization of P-type ATPases, using SERCA1a natively isolated from the fasttwitch muscle of rabbit as a test case. We believe the approach described here can easily be applied to other transporters, channels and receptors.
Membrane Protein Reconstitution
For the reconstitution into Salipro particles, membrane proteins may originate either from natural sources or from overexpression in appropriate expression systems, e.g., bacterial, yeast or mammalian system (Lyons, Shahsavar, Paulsen, Pedersen, & Nissen, 2016) . Membrane proteins require solubilization in an appropriate detergent, followed by one or more purification steps. The choice of detergent is often critical as some detergents might severely reduce the stability of the protein.
As this is generally established on a case-to-case basis, we will not describe these initial steps here (for review, see (Loll, 2014) ), but instead start with the final purification step before Salipro reconstitution.
Once the sample of pure solubilized membrane protein is available, reconstitution into Salipro can proceed quite straightforwardly, with purification by a final size exclusion chromatography step to separate the reconstituted membrane proteinSalipro particle from free saposin, lipid-only (empty) Salipro particles and potential aggregates. However, while the reconstitution protocol is fast, it will likely require some screening of the various parameters to find the optimal strategy for reconstitution. The choice of lipid(s) to use could be one such parameter, along with incubation times and temperature, and ratios between the target protein, saposin and lipid(s).
Saposin Purification
Saposin proteins are capable of binding lipids. This class of proteins is composed of amphipathic helices with hydrophobic amino acids that build the protein core, and six invariable cysteine residues that form disulphide bridges that lead to an extraordinary stability of the domains. • Centrifuges for the harvesting of E. coli cells (at least 6,000 x g) and a standard refrigerated centrifuge capable of speeds of up to 26,000 x g
• Probe sonicator suitable for lysing E. coli.
• Water bath 3. Protein expression is induced at OD600 nm of 1.0 with 0.7 mM IPTG at 37°C.
Three hours after induction, cells are harvested at 12,000×g for 20 minutes.
At this point, cells can be frozen for long-term storage in a -80°C freezer.
4. For purification, cells are resuspended in Lysis buffer (1 g of cell wet weight in 5 ml lysis buffer) and disrupted by sonication.
5. Cell debris is removed by centrifugation at 26,000×g for 30 min at 4°C.
6. In a waterbath, the supernatant is incubated at 85 °C for 10 min.
7. The supernatant is subjected to a second centrifugation step at 26,000×g for 30 min at 4°C. 12. Saposin A is eluted by adding 5 CV of Elution buffer.
13. Saposin A is subsequently dialyzed against Size Exclusion buffer together with TEV protease overnight in a dialysis bag at 4 °C with gentle stirring.
14. To remove TEV protease and uncleaved proteins, the sample is passed over equilibrated IMAC beads again and the flow through collected and concentrated using Amicon Ultra concentrators to a volume of 5 ml.
15. Using an ÄKTA chromatography system, the sample is loaded onto a HiLoad Superdex 200 16/600 GL column, equilibrated with at least two column volumes of Size Exclusion buffer, and fractions are collected.
16. Peak fractions are pooled and concentrated to 1.2 mg/ml protein using an Amicon Ultra concentrator.
17. Aliquot and flash freeze purified saposin A in liquid nitrogen for storage at -80 °C.
Notes
1. Typically, a 1-liter bacterial culture yields 5-10 mg of purified saposin.
SERCA Purification
For the purpose of this protocol, it is assumed that one has a purified membrane protein, therefore details pertaining to the expression and purification strategies will not be discussed in detail here. The protocol will begin from the polishing of the detergent solubilized protein via size exclusion chromatography, along with considerations for use of detergents. SERCA is natively isolated from rabbit fasttwitch muscle (Møller & Olesen, 2016) .
The optimal starting point is a monodisperse peak in the size exclusion chromatogram, indicating a stable and homogenous sample (Figure 1 ). Assuming the sample is not intended for activity assays, locking the protein in a specific state using an inhibitor or other ligands is advisable. 2. Pipette the sample into tubes compatible with ultracentrifugation and spin the sample at 50,000 rpm at 4 °C for 35 minutes to sediment aggregates.
3. Inject the sample onto a column equilibrated with at least two column volumes of Size Exclusion buffer, and collect fractions (250 -500 µL).
4. Run samples of the peak fractions on a 15% SDS-PAGE to check purity.
5. Collect pure peak fractions and concentrate to about 3 mg/ml. 6. Use directly for Salipro reconstitution or flash freeze in liquid nitrogen and store at -80 °C. For further analysis, peak fractions are collected to isolate Salipro-SERCA complexes.
In the case of SERCA, a careful collection of fractions might be required, due to the presence of two populations (monomers, dimers) of Salipro-SERCA. However, these are easily discriminated by particle size (Figure 2 ). Brain Lipids (5 ul at 5 mg/ml) and Saposin (20 ul at 1.2 mg/ml). After the addition of dilution buffer, the samples are subjected to a gel-filtration step, which allows to determine the optimal ratios for self-assembly of the Salipro particles.
2. Getting the Brain Lipid Extract stock solubilized might require alternating heating (55 °C), vortexing and bath sonication.
3. Other lipid mixtures can be used.
4. Screening for an optimum reconstitution protocol can be achieved using 2-10 µL of protein solution depending on the sensitivity of the detection of the chromatography system. 5. The throughput of the reconstitution protocol screening can be increased using automation and an autoloader.
6. An excess of saposin A is generally required for optimum reconstitution.
7. For the large scale preparation described above a number of reactions each with a final volume of 1 mL upon dilution (step4) are set up before pooling and concentrating with a spin filter of appropriate MW cut-off.
8. Adding 5-10% glycerol to the size exclusion buffer may further stabilize the membrane protein, especially when freezing/thawing, however the presence of glycerol might hamper the contrast in future cryo-EM studies for highresolution.
9. For larger membrane protein complexes, different column materials (e.g. Superose 6) may prove beneficial.
Electron Microscopy of Salipro Particles
Here we describe how to image the SERCA-Salipro particles using negative stain EM and how to reconstruct a 3D volume from the data. Compared to cryo-EM, negative stain EM has a very limited maximum resolution, revealing only the overall shape of imaged particles. However, sample preparation is quick and the contrast is high, making it well suited for screening samples before moving to high-resolution cryo-EM.
Equipment
• PELCO EasiGlow Glow Discharge Cleaning System
• Tecnai G2 Spirit electron microscope equipped with an LaB6 filament and operated at an acceleration voltage of 120 kV and a Tietz F415 CCD camera with 4k×4k pixels
• Leginon data acquisition software (Suloway et al., 2005) • Appion data processing suite (Lander et al., 2009) • EMAN software ( (Ludtke, Baldwin, & Chiu, 1999) • RELION version 2.0 (Scheres, 2012) • Chimera software (Pettersen et al., 2004) • Computing resources -here we used a GPU cluster (Dell PowerEdge C4130 w/ 2 x Xeon E5-2620v4, 128 GB RAM, 4 x NVIDIA TESLA K80)
Buffers and Reagents
• Sample dilution buffer: 67 mM MOPS (pH 6.8), 100 mM KCl, 5 mM MgCl2, 4 mM EGTA, 0.5 mM BeSO4, 10 mM NaF
• SERCA1a-Salipro sample at 0.24 mg/mL
• Commercial copper G400-C3 grids overlaid with carbon, glow discharged at 25 mA for 45 s prior to use.
• 2 %(w/v) uranyl formate (Ohi, Li, Cheng, & Walz, 2004) Procedure 1. SERCA1a-Salipro complex is diluted six-fold using the sample dilution buffer to ~40 ug/mL in the presence of the conformation stabilizing (E2P) inhibitor BeFx (from BeSO4 and NaF) and incubated on ice for 1 h.
2. 3 uL of protein solution was added to a freshly glow discharged grid.
3. After ~10 seconds, the excess protein solution was removed by blotting the edge of the grid against a piece of Whatman grade 4 filter paper.
4. 3 uL of 2 %(w/v) uranyl formate stain was immediately added and excess stain was removed by blotting the same edge of the grid as before against the filter paper.
5. Staining was repeated twice more as per step 3.
6. The grid was left to air dry for a few minutes before use.
7. Images were collected on a Tecnai G2 Spirit microscope using the automated data collection software, Leginon. 2. Protein concentration of the sample applied to the grid will have to be screened to obtain micrographs containing as many particles as possible, while still having them isolated from one another.
3. Data processing can be greatly enhanced and sped up using a GPU enabled workstation or cluster (Kimanius, Forsberg, Scheres, & Lindahl, 2016) .
Summary and Conclusion
Reconstitution of membrane proteins into Salipro nanoparticles follows a fairly straightforward protocol, and optimizations of e.g. lipid type, incubation time and temperature, and protein:saposin:lipid ratios can be screened on a small scale. For large-scale production, several methods can be used. One option is to perform several runs of the same reconstitution with subsequent purification on a mediumsized size-exclusion columns (24 ml), and then pooling the relevant peak fractions from each SEC run and concentrating, as described earlier (Frauenfeld et al, 2016) .
Another approach is presented here, where several reconstitution mixtures are pooled and concentrated prior to purification on a medium-sized size-exclusion column.
Alternatively, it is possible to perform the reconstitution with higher amounts and volumes (up to 5 ml) and inject the mixture on a size-exclusion column with larger volume (120 ml). However this large-column approach should only be performed if reconstitution conditions are well established on the small-and medium scale.
Preparing grids with Salipro samples and collecting data can be performed on the same day as reconstitution, especially with the help of data collection software such as Appion. Nevertheless, for SERCA-Salipro we could also flash-freeze samples and thaw later for grid preparation without significant aggregation observed in the micrographs.
Given the small size of the particle imaged here, and with the use of a GPU-cluster to accelerate processing, we were able to go from micrographs to 3D volume in a few days. The generated 3D volume fits the crystallographic model very well, and it is worth noting that SERCA at 110 kDa is still on the small side of what can be characterized to high resolution using cryo-EM.
We have found these procedures to work well for a range of P-type ATPases and other transporters, and are currently exploring the possibilities for also extracting Salipro particles directly from native membranes. There are also interesting applications to small-angle scattering studies, and expressed in E. coli, saposin can be subjected to deuteration for neutron scattering studies. It remains to be seen if Salipro complexes of membrane proteins can be crystallized, but given the rather adaptive and dynamic nature of the Salipro interaction it would not seem unfeasible. Peak 1 is at the void volume and was discarded, as was peak 2 which might correspond to SERCA dimers. Peak 3 contains purified SERCA monomer and was collected for SERCA-Salipro reconstitution.
Figure Legends

Figure 2
Elution profile from size exclusion chromatography (SEC) of SERCA-Salipro reconstitution. Peak 2 contains the SERCA monomers used for negative stain cryo-EM. Peak 1 likely contains SERCA dimers reconstituted in Salipro, but with careful fractionation a sample of almost pure monomeric form could be obtained, as evident from the micrographs and class averages (Figure 3 ). Peak three is composed of lipid-only (empty) Salipro particles. Typically, a peak corresponding to free saposin A is evident at ~17.5 mL, however concentration of the sample using a 100 KDa MWCO spin filter prior to injection to SEC can decrease the concentration of saposin A and possibly the empty salipro nanoparticles with respect to the protein of interest. 
